These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 10935251

  • 21. Macrophages and neurodegeneration.
    Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD.
    Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
    [Abstract] [Full Text] [Related]

  • 22. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N, Ben-Hur T, Karussis D, Milonas I.
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [Abstract] [Full Text] [Related]

  • 23. Extensive acute axonal damage in pediatric multiple sclerosis lesions.
    Pfeifenbring S, Bunyan RF, Metz I, Röver C, Huppke P, Gärtner J, Lucchinetti CF, Brück W.
    Ann Neurol; 2015 Apr; 77(4):655-67. PubMed ID: 25612167
    [Abstract] [Full Text] [Related]

  • 24. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S, Dallenga T, Winkler A, Roemer S, Maruschak B, Siebert H, Brück W, Stadelmann C.
    J Neuroinflammation; 2017 Mar 17; 14(1):57. PubMed ID: 28302146
    [Abstract] [Full Text] [Related]

  • 25. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

  • 26. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W.
    Brain; 2000 Jun 14; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [Abstract] [Full Text] [Related]

  • 27. Demyelination and axonal damage in a non-human primate model of multiple sclerosis.
    Mancardi G, Hart B, Roccatagliata L, Brok H, Giunti D, Bontrop R, Massacesi L, Capello E, Uccelli A.
    J Neurol Sci; 2001 Feb 15; 184(1):41-9. PubMed ID: 11231031
    [Abstract] [Full Text] [Related]

  • 28. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N, Bö L, Hoek RM, Huitinga I.
    Ann Neurol; 2007 Nov 15; 62(5):504-14. PubMed ID: 17879969
    [Abstract] [Full Text] [Related]

  • 29. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R, Sepcić J.
    Lijec Vjesn; 2006 Nov 15; 128(9-10):295-308. PubMed ID: 17128669
    [Abstract] [Full Text] [Related]

  • 30. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
    Kouwenhoven M, Ozenci V, Gomes A, Yarilin D, Giedraitis V, Press R, Link H.
    J Autoimmun; 2001 Jun 15; 16(4):463-70. PubMed ID: 11437495
    [Abstract] [Full Text] [Related]

  • 31. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A, Corkill R, Blamire AM, Palace J, Narayanan S, Arnold D, Styles P, Matthews PM.
    J Neurol; 2003 Feb 15; 250(2):171-8. PubMed ID: 12574947
    [Abstract] [Full Text] [Related]

  • 32. Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions.
    Zhang Y, Da RR, Hilgenberg LG, Tourtellotte WW, Sobel RA, Smith MA, Olek M, Nagra R, Sudhir G, van den Noort S, Qin Y.
    J Neuroimmunol; 2005 Oct 15; 167(1-2):120-30. PubMed ID: 16099056
    [Abstract] [Full Text] [Related]

  • 33. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.
    Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W.
    Brain; 2002 Oct 15; 125(Pt 10):2202-12. PubMed ID: 12244078
    [Abstract] [Full Text] [Related]

  • 34. Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury.
    Marmarou CR, Povlishock JT.
    Exp Neurol; 2006 Feb 15; 197(2):353-62. PubMed ID: 16297913
    [Abstract] [Full Text] [Related]

  • 35. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger.
    Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG.
    Proc Natl Acad Sci U S A; 2004 May 25; 101(21):8168-73. PubMed ID: 15148385
    [Abstract] [Full Text] [Related]

  • 36. Axonal damage in acute multiple sclerosis lesions.
    Ferguson B, Matyszak MK, Esiri MM, Perry VH.
    Brain; 1997 Mar 25; 120 ( Pt 3)():393-9. PubMed ID: 9126051
    [Abstract] [Full Text] [Related]

  • 37. Polyethylene glycol treatment after traumatic brain injury reduces beta-amyloid precursor protein accumulation in degenerating axons.
    Koob AO, Borgens RB.
    J Neurosci Res; 2006 Jun 25; 83(8):1558-63. PubMed ID: 16555285
    [Abstract] [Full Text] [Related]

  • 38. Protecting axons in multiple sclerosis.
    Wilkins A, Scolding N.
    Mult Scler; 2008 Sep 25; 14(8):1013-25. PubMed ID: 18632772
    [Abstract] [Full Text] [Related]

  • 39. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J, Pelletier D, Nelson SJ.
    Arch Neurol; 2004 Jul 25; 61(7):1081-6. PubMed ID: 15262739
    [Abstract] [Full Text] [Related]

  • 40. [Axonal degeneration in the pathogenesis of multiple sclerosis].
    Mirowska D, Członkowska A.
    Neurol Neurochir Pol; 2002 Jul 25; 36(4):777-89. PubMed ID: 12418141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.